We have designed and piloted for feasibility [29] an education and system-change intervention (the Stepping Up Program—described in more detail below) to facilitate general practice-based insulin initiation in people with T2D and suboptimal glycaemic outcomes who are on maximum oral therapy. This evidence concerns the gene INS and type 2 diabetes mellitus.